Patent US616895A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4336248A Expired / Lapsed US ⏱️ 0.0 years remaining

Preparation of coupled hemoglobin molecules

Assignee: Biotest AG
•
Filing: 1975-10-20
•
Granted: 1982-06-22
•
Expires: 1995-10-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Hemoglobin molecules are coupled so as to increase their intravascular residence times without significantly diminishing their oxygen transport ability. This is achieved by coupling hemoglobin molecules to one another and/or to serum proteins and gelatin derivatives using dialdehydes such as aliphatic dialdehydes of 3 to 8 carbon atoms, optionally followed by addition of pyridoxal phosphate. The desired material isolated by ammonium sulfate precipitation, the sulfate being added before, simultaneously with, or after the dialdehyde. Solution of the precipitate followed by dialysis and/or ion exchange can also be undertaken.

Inventors

  • 👤 Klaus Bonhard
  • 👤 Uwe Boysen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 11:56
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/795; C07K14/805; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 95 words
A chemically modified, stable hemoglobin preparation suitable for blood replacement and for organ perfusion, comprising hemoglobin molecules coupled to one another or to another protein selected from the group consisting of serum proteins and gelatin derivatives by a coupling reagent comprising an aliphatic dialdehyde having 3 to 8 carbon atoms, molar ratio of the coupling reagent to the hemoglobin being about 6:1 to about 18:1, the preparation having a capacity to transport oxygen corresponding approximately to that of free hemoglobin, and a blood residence time which is at least about twice that of free hemoglobin.
Claim 2
Dependent Claim 95 words
A chemically modified, stable hemoglobin preparation suitable for blood replacement and for organ perfusion, comprising hemoglobin molecules coupled to one another or to another protein selected from the group consisting of serum proteins and gelatin derivatives by a coupling reagent comprising an aliphatic dialdehyde having 3 to 8 carbon atoms, molar ratio of the coupling reagent to the hemoglobin being about 6:1 to about 18:1, the preparation having a capacity to transport oxygen corresponding approximately to that of free hemoglobin, and a blood residence time which is at least about twice that of free hemoglobin.
Claim 3
Dependent Claim 42 words
A process for producing a hemoglobin preparation according to claim 1, comprising adding to substantially oxygen-free hemoglobin the dialdehyde coupling reagent in a molar ratio of the dialdehyde to the hemoglobin of about 6:1 to about 18:1 and isolating the coupled hemoglobin.
Claim 4
Dependent Claim 56 words
The process of claim 2 comprising adding pyridoxal phosphate to the reaction mixture of the hemoglobin and the dialdehyde and wherein, after the pyridoxal phosphate has been added, the coupled hemoglobin is isolated as a precipitate by salting out with ammonium sulfate and, then, the ammonium sulfate in the product is partly replaced with sodium chloride.
Claim 5
Dependent Claim 23 words
The process of claim 2 wherein the dialdehyde is added as a solution in at least one of water and a lower alkanol.
Claim 6
Dependent Claim 20 words
The process of claim 4 wherein the aldehyde is added to and mixed with the hemoglobin under a nitrogen atmosphere.
Claim 7
Dependent Claim 20 words
The process of claim 2 wherein the coupled hemoglobin is isolated as a precipitate by salting out with ammonium sulfate.
Claim 8
Dependent Claim 17 words
The process of claim 6 wherein the ammonium sulfate is present in the hemoglobin prior to coupling.
Claim 9
Dependent Claim 16 words
The process of claim 4 wherein ammonium sulfate is added to the hemoglobin with the dialdehyde.
Claim 10
Dependent Claim 17 words
The process of claim 6 wherein the ammonium sulfate is added to the hemoglobin preparation after coupling.
Claim 11
Dependent Claim 18 words
The process of claim 6 including the further steps of dissolving the precipitate, and removing ammonium sulfate therefrom.
Claim 12
Dependent Claim 23 words
The process of claim 1 wherein serum albumin momlecules are present along with the hemoglobin molecules and are coupled to the hemoglobin molecules.
Claim 13
Dependent Claim 23 words
The process of claim 2 wherein gelatin derivative molecules are present along with the hemoglobin molecules and are coupled to the hemoglobin molecules.

References Cited (Backward Citations)

US3925344A Cited
US4001200A Cited
US4009267A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-06-21 1985-12-21 1986-06-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-06-21 1989-12-21 1990-06-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-06-21 1993-12-21 1994-06-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag